Immune-related adverse events in melanoma:A nationwide analysis 2016.

被引：0
|
作者：
Rai, Manoj P.
Bedi, Prabhjot Singh
Vishwanth, Rohanlal
Abu Rous, Fawzi
Shrotriya, Shiva
Dhakal, Prajwal
机构：
[1] Michigan State Univ, Sparrow Hosp, E Lansing, MI 48824 USA
[2] UPMC East, Pittsburgh, PA USA
[3] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA
[4] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e18253
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18253
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Intracranial Tumor Control Following Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma
    Zhang, Michael
    Rodrigues, Adrian
    Bhambhvani, Hriday
    Fatemi, Parastou
    Pollom, Erqi
    Gibbs, Iris
    Thomas, Reena
    Hancock, Steven
    Soltys, Scott G.
    Chang, Steven D.
    Reddy, Sunil
    Hayden, Melanie
    Li, Gordon
    NEUROSURGERY, 2020, 67 : 292 - 292
  • [42] Corticosteroids and second-line immunosuppressants for immune-related adverse events and melanoma survival
    Verheijden, R. J.
    Janssen, J. C.
    Putker, A. E.
    Veenstra, S. P. G. R.
    Hospers, G. A. P.
    Aarts, M. J. B.
    Hehenkamp, K. W.
    Doornebosch, V. L. E.
    Verhaert, M.
    Van den Berkmortel, F. W. P. J.
    Burgers, F. H.
    Haanen, J. B. A. G.
    Piersma, D.
    Kapiteijn, E.
    Labots, M.
    Boers-Sonderen, M. J.
    Van der Veldt, A. A. M.
    Aspeslagh, S.
    May, A. M.
    Suijkerbuijk, K. P. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S690 - S691
  • [43] Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab
    Tirumani, Sree Harsha
    Ramaiya, Nikhil H.
    Keraliya, Abhishek
    Bailey, Nancy D.
    Ott, Patrick A.
    Hodi, F. Stephen
    Nishino, Mizuki
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10) : 1185 - 1192
  • [44] Nivolumab in resected and unresectable melanoma: Immune-related adverse events and association with survival outcomes
    Freeman-Keller, Morganna L.
    Weber, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events
    Mueller, Benjamin
    Baerenwaldt, Anne
    Herzig, Petra
    Zippelius, Alfred
    Maul, Lara Valeska
    Hess, Viviane
    Koenig, David
    Laeubli, Heinz
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Analysis of Immune-Related Adverse Events of Pembrolizumab Using FAERS Database
    Tan, Feilong
    Zhou, Li
    Huang, Guijiang
    Li, Yanhua
    Yin, Wenjie
    Xia, Hongying
    ONCOLOGY, 2025,
  • [47] Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors
    Pan, Catherina X.
    Liu, Mofei
    Lau, Charles B.
    Lau, William C.
    Kim, Daniel Y.
    Saberi, Shahin A.
    Rowley, Rachael
    Kanwar, Ruhi
    Giobbie-Hurder, Anita
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (04) : 826 - 829
  • [48] Trends in immune-related adverse events for colorectal cancer: A bibliometric analysis
    Cui, Jin
    Xiong, Ying
    Sun, Min
    Gu, Xinyue
    Liu, Yuting
    Zhong, Luhui
    Hong, Xiaohua
    Liu, Li
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Immune-Related Adverse Events From Immune Checkpoint Inhibitors
    Marrone, K. A.
    Ying, W.
    Naidoo, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (03) : 242 - 251
  • [50] Comparative incidence and severity of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors
    Pan, Catherina
    Kim, Daniel
    Lau, Charles
    Lau, William
    Rowley, Rachael
    Kanwar, Ruhi
    LeBoeuf, Nicole
    Nambudiri, Vinod
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB27 - AB27
12345